An overview of key potential therapeutic strategies for combat in the COVID-19 battle

G Das, S Ghosh, S Garg, S Ghosh, A Jana, R Samat… - Rsc Advances, 2020 - pubs.rsc.org
The sudden ravaging outbreak of a novel coronavirus, or SARS-CoV-2, in terms of virulence,
severity, and casualties has already overtaken previous versions of coronaviruses, like …

Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection

G Krishna, VS Pillai, MV Veettil - European Journal of Pharmacology, 2020 - Elsevier
Virus onslaughts continue to spread fear and cause rampage across the world every now
and then. The twenty first century is yet again witnessing a gross global pandemic …

Update on antiviral strategies against COVID-19: unmet needs and prospects

CH Liu, CH Lu, SH Wong, LT Lin - Frontiers in Immunology, 2021 - frontiersin.org
By December 2020, the COVID-19 pandemic had caused more than 74 million confirmed
cases and 1.6 million related deaths around the world. However, only a few drugs have …

Potential approaches to combat COVID-19: a mini-review

Z Sarwar, T Ahmad, S Kakar - Molecular Biology Reports, 2020 - Springer
The outbreak of a novel coronavirus namely SARS-CoV-2, which first emerged from Wuhan,
China, has wreaked havoc not only in China but the whole world that now has been …

SARS-coV-2 treatment approaches: numerous options, no certainty for a versatile virus

S Iacob, DG Iacob - Frontiers in Pharmacology, 2020 - frontiersin.org
SARS-CoV-2 is the most recent coronavirus which crossed the species barrier in 2019 and
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …

Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future

M Rehman, I Tauseef, B Aalia, SH Shah, M Junaid… - Future …, 2020 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019. It was first reported in Wuhan, China and has since become a …

A review of SARS-CoV-2 and the ongoing clinical trials

YF Tu, CS Chien, AA Yarmishyn, YY Lin… - International journal of …, 2020 - mdpi.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

A review of SARS-CoV-2 and the ongoing clinical trials

T Yung-Fang, CS Chien, AA Yarmishyn… - International …, 2020 - search.proquest.com
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in
Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a …

New therapeutic approaches for SARS-CoV-2/COVID-19

AJ Rodriguez-Morales, AN Barbosa… - Frontiers in …, 2023 - frontiersin.org
After three years and a half since the pandemic due to the Severe Acute Respiratory
Syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) …

[HTML][HTML] Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review

M Goyal, N Tewatia, H Vashisht, R Jain… - Journal of Infection and …, 2021 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19), associated with the outbreak of deadly
virus originating in Wuhan, China, is now a global health emergency and a matter of serious …